Charles river introduces cliniprime cryopreserved leukopaks, expanding suite of gmp-compliant cellular products

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) today announced the expansion of its cliniprime™ suite of good manufacturing practice (gmp)-compliant offerings with the launch of cliniprime cryopreserved leukopaks for cell therapy development and manufacturing. all cliniprime products meet regulatory guidelines for clinical trial development and commercial manufacturing of advanced therapies. as advances in gene-modified cell therapies continue, th.
CRL Ratings Summary
CRL Quant Ranking